News

A researcher says the experimental use of gene therapy for a rare inherited disorder is saving almost as much money for ...
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
Is the day of the zombie biotech coming to an end? Eyes have it: Peninsula biotech focuses on glaucoma, more in big test Eyes have it: Peninsula biotech focuses on glaucoma, more in big test © 2025 ...
A new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness ...
The state-of-the-art technique can improve hearing in children and adults with congenital deafness or severe hearing ...
The state of the art technique can improve hearing in children and adults with congenital deafness or severe hearing ...
ProBio opens a 128,000-sq.-ft. gene therapy facility in Hopewell, creating 110+ jobs and advancing global cell and gene ...
Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany ...
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today ...
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with genetic diseases?
A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...
Isaralgagene civaparvovec is a “potential best-in-class gene therapy for Fabry disease,” according to analysts at H.C. Wainwright. Sangamo plans to use pivotal Phase I/II data to build an accelerated ...